Medical Journal Article Reports On Two Patients Who Experienced Severe Liver Damage Onset During Xarelto Treatment
SUMMARY: A recent article published by the medical journal JAMA Internal Medicine, “Symptomatic Hepatocellular Liver Injury With Hyperbilirubinemia in Two Patients Treated With Rivaroxaban”, discusses a newly-noted serious Xarelto side effect: drug-induced liver injury / liver damage
From a medical site summary about this recent Xarelto liver safety study, “Rivaroxaban and Liver Injury: Case Studies Add to Safety Questions”, we get these facts:
A case study in JAMA Internal Medicine reports on two patients that experienced severe liver injury onset during treatment with the oral anticoagulant [Xarelto (rivaroxaban)]. The first patient was a 52-year-old man who developed severe lobular hepatitis two months after initiation of [Xarelto (rivaroxaban)]…. The second patient, a 73-year-old woman prescribed 10mg/day of [Xarelto (rivaroxaban)] after a total knee replacement for the prevention of DVT, experienced mixed liver injury….
We will continue to watch for liver failure, drug-induced hepatitis, and liver damage drug injury cases possibly associated with Xarelto blood thinner treatment.[Read this article in full at original source]
Strictly Confidential, No Obligation